Pancreatic Cancer Research

ResearcherInstitut Paoli-CalmettesNo recent work listed

Fabrice Caillol

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-4186-0942; OpenAlex author ID A5017732235. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
10
Papers, trials and grants by year

2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 1 paper

Papers 2

  1. A Transcriptomic-Based Tool to Predict Gemcitabine Sensitivity in Advanced Pancreatic Adenocarcinoma. Co-author DOI 10.1053/j.gastro.2022.11.035↗
  2. Pancreatic Adenocarcinoma with Early Intense Enhancement in Harmonic Contrast-Endoscopic Ultrasound and High Strain Ratio in Elastometry (with video). Co-author DOI 10.4103/2303-9027.117722↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Flora Poizat · 2 shared papers, 2013–2023 · strength 0.18
  2. Marc F. Giovannini · 2 shared papers, 2013–2023 · strength 0.18
  3. Fabio Giannone Codiglione · 1 shared paper, 2023 · strength 0.14
  4. Emmanuel Mitry · 1 shared paper, 2023 · strength 0.14
  5. Patrick Pessaux · 1 shared paper, 2023 · strength 0.14
  6. Rémy Nicolle · 1 shared paper, 2023 · strength 0.14
  7. Nicolas Alejandro Fraunhoffer · 1 shared paper, 2023 · strength 0.14
  8. Brice Chanez · 1 shared paper, 2023 · strength 0.14
  9. Juan Iovanna · 1 shared paper, 2023 · strength 0.14
  10. Nelson Dusetti · 1 shared paper, 2023 · strength 0.14

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.